Cytokine response in lower extremity ischaemia/reperfusion

Journal of International Medical Research

Volumn 32, Issue 2, 2004, Pages 124-131

  Ege, T ^a   Us, M H ^b   Sungun, M ^b   Duran, E ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

Acute arterial occlusion; Alveolar arterial gradient; Cytokines; Ischaemia reperfusion

Indexed keywords

CREATINE KINASE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ADULT; AGED; ARTERIAL BLOOD; ARTERIAL OXYGEN TENSION; ARTERY OCCLUSION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; EMBOLECTOMY; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEG ISCHEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG INJURY; MALE; RADIAL ARTERY; REPERFUSION INJURY; THROMBOEMBOLISM;

EID: 1642487754     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000403200204     Document Type: Article

References (23)

1. Harkin DW, Barros D'Sa AAB, McCallion K, Hoper M, Campbell FC: Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg 2002; 35: 1264 - 1272.
2. Crinnion JN, Homer-Vannaiasinkam S, Parkin SM, Gough MJ: Role of neutrophil-endothelial adhesion in skeletal muscle reperfusion injury. Br J Surg 1996; 83: 251 - 254.
3. Gaines GC, Welborn MB, Moldawer LL, Huber TS, Harward TRS, Seeger JM: Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor. J Vasc Surg 1999; 29: 370 - 376.
4. Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, Michael LH, et al: A chronic mouse model of myocardial ischemia-reperfusion: Essential in cytokine studies. Am J Physiol Heart Circ Physiol 2000; 278: H1049 - H1055.
5. Lawlor DK, Brock RW, Harris KA, Potter RF: Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia. J Vasc Surg 1999; 30: 533 - 541.
6. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Susarla S, Czura CJ, et al: Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231 - 1236.
7. Czerny M, Baumer H, Kilo J, Lassnigg A, Hamwi A, Vukovich T, et al: Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 2000; 17: 737 - 742.
8. Wan S, Yim APC: 8 Cytokines In myocardial injury: impact on cardiac surgical approach. Eur J Cardiothorac Surg 1999; 16: S107 - S111.
9. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S: Cytokine gene expression after myocardial infarction in rat hearts. Circulation 1998; 98: 149 - 156.
10. Boyle EM, Kovacich JC, Hebert CA, Canty TG, Chi E, Morgan EN, et al: Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1998; 116: 114 - 118.
11. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996; 224: 647 - 664.
12. Kunihara T, Sasaki S, Shiiya N, Miyatake T, Mafune N, Yasuda K: Proinflammatory cytokines in cerebrospinal fluid in repair of thoracoabdominal aorta. Ann Thorac Surg 2001; 71: 801 - 806.
13. Wan S, DeSement JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL: Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112: 806 - 811.
14. Ascer EA, Gennaro M, Cupo S, Mohan C: Do cytokines play a role in skeletal muscle ischemia and reperfusion? J Cardiovasc Surg 1992; 33: 588 - 592.
15. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA: Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia-reperfusion injury and associated lung injury. Am J Pathol 1993; 143: 453 - 463.
16. Ellery JM, Kempshall SJ, Nicholls PJ: Activation of the interleukin 2 receptor: A possible role for tyrosine phosphates. Cell Signal 2000; 12: 367 - 373.
17. Ellery JM, Nicholls PJ: Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev 2002; 13: 27 - 40.
18. Alter P, Hoeschen J, Ritter M, Maisch B: Usefulness of cytokines interleukin-6 and interleukin-2R concentrations in diagnosing active infective endocarditis involving native valves. Am J Cardiol 2002; 89: 1400 - 1404.
19. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, et al: IL-2 and autoimmune disease. Cytokine Growth Factor Rev 2002; 13: 369 - 378.
20. Alvarez-de-la-Rose M, Robello FJ, Codoceo R, Gonzales AG: Maternal serum interleukin 1, 2, 6, 8 and interleukin-2 receptor levels in preterm labor and delivery. Eur J Obstet Gynecol Reprod Biol 2000; 88: 57 - 60.
21. Sorichter S, Mair J, Koller A, Müller E, Kremser C, Judmaier W, et al: Skeletal muscle troponin I release and magnetic resonance imaging signal intensity changes after eccentric exercise-induced skeletal muscle injury. Clin Chim Acta 1997; 262: 139 - 146.
22. Makinen TM, Rintamaki H, Korpakka J, Komulainen J, Hissa R: Submaximal exercise in the cold: Does cooling potentiate the development of muscle injuries in the rat? Comp Biochem Physiol A Mol Integr 1998; 121: 273 - 278.
23. Muders F, Neubauer S, Luchner A, Fredersdorf S, Ickenstein G, Riegger GAJ, et al: Alterations in myocardial creatinine kinuse (CK) and lactate dehydrogenase (LDH) isoenzyme-distribution in a model of left ventricular dysfunction. Eur J Heart Fail 2001; 3: 1 - 5.